Skip to main content
. 2022 Jul 28;53(4):511–531. doi: 10.1080/03036758.2022.2101483

Table 3.

FTDGeNZ baseline demographic and clinical data.

  Mutation carriers
(n = 6)
Non-carriers
(n = 19)
p-value
No. female (%) 4 (67) 6 (32) .175
Age (years) 41 ± 11.7 44 ± 15.9 .624
Education (years) 12.7 ± 1.6 14.4 ± 2.0 .061
Asymptomatic (%) 6 (100) 19 (100) >.999
Years from estimated onset −12.5 ± 11.3
CBI-R* 16.0 ± 8.3 9.1 ± 8.1 .152
ACE-III 91.2 ± 2.9 93.5 ± 5.2 .192

*Baseline CBI-R was missing for 1 mutation carrier and 3 non-carriers.

ACE-III: Addenbrooke’s Cognitive Examination III; CBI-R: Cambridge Behavioural Inventory – Revised.

Data shown are count (percentage), or mean ± standard deviation. p-values calculated from Fisher’s exact test or Student’s t-test.